Details of the Drug Reposition

General Information of This Drug (ID: DM9LKYP)

Drug Name	AZ-40140 DM9LKYP

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Type-2 diabetes	DIS3X247	5A11	Phase 2	[1]
Obesity	DIS47Y1K	5B81	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.